FDA product code OCC: Respiratory Virus Panel Nucleic Acid Assay System

OCC is the FDA product code for respiratory virus panel nucleic acid assay system. It is a Class II device, regulated under 21 CFR 866.3980 and reviewed by the Microbiology panel. FDA has cleared 79 510(k) submissions under OCC, 6 in the last five years, from 30 different applicants. The average 510(k) review took 97 days (median 85); 54 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 25 recalls for OCC devices, 6 initiated in the last five years.

Definition

A respiratory viral panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple viral nucleic acids extracted from human respiratory specimens or viral culture. The detection and identification of a specific viral nucleic acid from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection when used in conjunction with other clinical and laboratory findings. The device is intended for detection and identification of a combination of the following viruses: Influenza A and Influenza B, Influenza A subtype H1 and Influenza A subtype H3, Respiratory Syncytial Virus subtype A and Respiratory Syncytial Virus subtype B, Parainfluenza 1, Parainfluenza 2, and Parainfluenza 3 virus, Human Metapneumovirus, Rhinovirus, and Adenovirus.

Classification

FieldValue
Device nameRespiratory Virus Panel Nucleic Acid Assay System
Device classClass II
Regulation21 CFR 866.3980
Review panelMI — Microbiology
Medical specialtyMicrobiology
Premarket route510(k)

510(k) clearances per year for OCC

YearClearancesAvg. review days
201710145
20184120
2019567
2020253
2021119
20221210
2023227
2024129
2026279

Compare with all 510(k) review times · Search every OCC clearance

Top OCC applicants

ApplicantClearancesLatest
Luminex Molecular Diagnostics, Inc.82024-10-02
Cepheid82018-08-15
Nanosphere, Inc.62015-09-04
Alere Scarborough, Inc.52018-01-26
Hologic, Inc.42023-05-05

25 more applicants have OCC clearances. See the full list in Caduvo.

Most recent OCC clearances

510(k)ApplicantDeviceDecision dateReview days
K262747Abbott Diagnostics Scarborough, Inc.ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.02026-08-3128
K254139Applied BioCode, Inc.BioCode® Respiratory Pathogen Panel (RPP)2026-05-01130
K242613Luminex Molecular Diagnostics, Inc.NxTAG® Respiratory Pathogen Panel2024-10-0229
K232775Abbott Diagnostics Scarborough, Inc.ID NOW Influenza A & B 22023-10-1029
K231017Hologic, Inc.Panther Fusion AdV/hMPV/RV Assay2023-05-0525

Recalls for OCC devices

25 product recalls in 20 recall events; 6 initiated in the last five years and 15 still open. Most recent: 2025-04-30.

YearRecalls
20171
20181
20192
20206
20231
20242
20253

Frequently asked questions

What is FDA product code OCC?

OCC is the FDA product code for respiratory virus panel nucleic acid assay system. It is a Class II device, regulated under 21 CFR 866.3980 and reviewed by the Microbiology panel.

What device class is OCC?

Class II, regulation 21 CFR 866.3980. Typical premarket route: 510(k).

How long does a 510(k) take for product code OCC?

Across 79 cleared submissions the average was 97 days from receipt to decision (median 85).

Which companies have the most OCC clearances?

Luminex Molecular Diagnostics, Inc. (8); Cepheid (8); Nanosphere, Inc. (6); Alere Scarborough, Inc. (5); Hologic, Inc. (4).

Have OCC devices been recalled?

Yes: 25 product recalls across 20 recall events; the most recent began 2025-04-30.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times